母亲接种疫苗对婴儿期危及生命的呼吸道合胞病毒感染的可能影响
研究建立数学模型模拟母亲接种呼吸道合胞病毒(RSV)疫苗后的抗体动态,并应用于英国370例、荷兰167例因RSV入住儿科重症监护病房(PICU)的12月龄以下儿童队列及20国211例RSV相关院内死亡儿童队列。模型预测孕30周接种疫苗可分别预防英国62-75%、荷兰76-87%的RSV相关PICU入住及全球29-48%的RSV相关院内死亡。早产儿和合并症儿童获益可能低于健康足月儿。
要点
- 模型预测孕30周接种RSV疫苗可预防英国62-75%、荷兰76-87%的RSV相关PICU入住。
- 全球队列中,孕30周接种RSV疫苗可预防29-48%的RSV相关院内死亡。
- 早产儿和合并症儿童从母亲接种疫苗中的获益可能低于健康足月儿。
核心结论
- 母亲接种RSV疫苗可能大幅减少婴儿危及生命的RSV感染。
研究设计与样本
- 建立母亲疫苗诱导抗体动态的数学模型,使用目前处于3期临床开发的母亲RSV疫苗特征。
- 模型应用于英国370例和荷兰167例12月龄以下因RSV入住PICU的儿童队列,以及20国211例12月龄以下RSV相关院内死亡儿童队列。
主要发现
- 模型预测,取决于疫苗效率,孕30周接种母亲疫苗可预防英国62-75%的RSV相关PICU入住,荷兰76-87%。
- 全球死亡队列中,模型预测母亲接种疫苗可预防29-48%的RSV相关院内死亡。
- 预测早产儿和合并症儿童获益少于健康足月儿。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Respiratory syncytial virus (RSV) infection is an important cause of infant mortality. Here, we estimated the potential impact of maternal vaccination against RSV on life-threatening RSV infection in infants. METHODS: We developed a mathematical model for maternal vaccine-induced antibody dynamics and used characteristics of a maternal RSV vaccine currently in phase 3 of clinical development. The model was applied to data from two cohorts of children younger than 12 months with RSV-related paediatric intensive care unit (PICU) admission in the United Kingdom (n = 370) and the Netherlands (n = 167), and a cohort of 211 children younger than 12 months with RSV-related in-hospital death from 20 countries worldwide. RESULTS: Our model predicted that, depending on vaccine efficiency, maternal vaccination at 30 weeks' gestational age could have prevented 62-75% of RSV-related PICU admissions in the United Kingdom and 76-87% in the Netherlands. For the global mortality cohort, the model predicted that maternal vaccination could have prevented 29-48% of RSV-related in-hospital deaths. Preterm children and children with comorbidities were predicted to benefit less than (healthy) term children. CONCLUSIONS: Maternal vaccination against RSV may substantially decrease life-threatening RSV infections in infants.
引用
- Scheltema NM, Kavelaars XM, Thorburn K, et al. Potential impact of maternal vaccination on life-threatening respiratory syncytial virus infection during infancy. Vaccine. 2018. PMID: 29941327. doi:10.1016/j.vaccine.2018.06.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。